Vaniprevir with peginterferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C - a randomized phase 2 study
Hepatology,  Clinical Article

Manns MP et al. – Vaniprevir is a potent hepatitis C virus (HCV) protease inhibitor with a predictable resistance profile and favorable safety profile that is suitable for once– or twice–daily administration.

Methods
  • In this double-blind, placebo-controlled, dose-ranging study, treatment-naive patients with HCV genotype 1 infection (n = 94) were randomized to receive open-label PEG-IFN alfa-2a (180 µg/week) and ribavirin (1,000-1,200 mg/day) in combination with blinded placebo or vaniprevir (300 mg bid, 600 mg bid, 600 mg qd, or 800 mg qd) for 28 days, and then open-label PEG-IFN alfa-2a and ribavirin for an additional 44 weeks.
  • The primary efficacy end point was rapid viral response (RVR), defined as undetectable plasma HCV RNA at week 4.
  • Across all doses, vaniprevir was associated with a rapid 2-phase decline in viral load, with HCV RNA levels approximately 3 log10 IU/mL lower in vaniprevir-treated patients compared with placebo recipients.

Results
  • Across all doses, vaniprevir was associated with a rapid 2-phase decline in viral load, with HCV RNA levels approximately 3 log10 IU/mL lower in vaniprevir-treated patients compared with placebo recipients.
  • There were numerically higher, but not statistically significant, early and sustained virologic response rates with vaniprevir as compared with placebo.
  • Resistance profile was predictable with variants at R155 and D168 detected in a small number of patients.
  • No relationship between IL28B genotype and treatment outcomes was demonstrated in this study.
  • The incidence of adverse events was generally comparable between vaniprevir and placebo recipients; however, vomiting appeared to be more common at higher vaniprevir doses.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

1 Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits Complementary Therapies in Medicine, June 17, 2014    Review Article

2 Statins in the elderly: an answered question Current Opinion in Cardiology, June 9, 2014    Evidence Based Medicine    Review Article    Clinical Article

3 Efficacy of high-dose versus standard-dose influenza vaccine in older adults New England Journal of Medicine, August 15, 2014    Evidence Based Medicine    Clinical Article

4 Hepatitis a hospitalizations in the United States, 2002 – 2011 Hepatology, October 3, 2014    Clinical Article

5 A statin a day to keep the doctor away? comparing aspirin and statins for primary prevention of cardiovascular disease Annals of Pharmacotherapy, August 7, 2014    Clinical Article

6 Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

7 Consumption of nuts and legumes and risk of stroke: a meta-analysis of prospective cohort studies Nutrition, Metabolism & Cardiovascular Diseases, July 25, 2014    Evidence Based Medicine    Clinical Article

8 Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012 Full Text PLoS Medicine, October 10, 2014    Free full text    Evidence Based Medicine    Clinical Article

9 Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial JAMA, October 10, 2014    Evidence Based Medicine    Clinical Article

10 The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: A cohort study International Journal of Cardiology, June 27, 2014    Clinical Article

11 Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians’ Health Study II randomized trial American Journal of Clinical Nutrition, July 10, 2014    Clinical Article

12 The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: Results of a randomized trial American Heart Journal, October 3, 2014    Clinical Article

13 Meta-analysis of non-steroidal anti-inflammatory drug use and risk of atrial fibrillation The American Journal of Cardiology, October 3, 2014    Evidence Based Medicine    Review Article    Clinical Article

14 Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease Clinical Rheumatology, October 10, 2014    Clinical Article

15 Calcium channel blocker compared with angiotensin receptor blocker for patients with hypertension: a meta-analysis of randomized controlled trials The Journal of Clinical Hypertension, August 13, 2014    Evidence Based Medicine    Review Article    Clinical Article

16 Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C Hepatology, October 3, 2014    Clinical Article

17 Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children The Journal of Allergy and Clinical Immunology, October 10, 2014    Clinical Article

18 The management of cirrhosis in women Alimentary Pharmacology and Therapeutics, October 10, 2014    Review Article

19 Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12 Journal of Clinical Oncology, October 17, 2014    Clinical Article

20 Management of high-grade gliomas in the elderly Seminars in Radiation Oncology, October 3, 2014    Clinical Article

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore